JPH01163123A - ビンクリスチン含有物 - Google Patents

ビンクリスチン含有物

Info

Publication number
JPH01163123A
JPH01163123A JP63281152A JP28115288A JPH01163123A JP H01163123 A JPH01163123 A JP H01163123A JP 63281152 A JP63281152 A JP 63281152A JP 28115288 A JP28115288 A JP 28115288A JP H01163123 A JPH01163123 A JP H01163123A
Authority
JP
Japan
Prior art keywords
vincristine
formula
salt
met
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63281152A
Other languages
English (en)
Japanese (ja)
Inventor
Victor J Nickolson
フイクトール・ヨハンネス・ニコルソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of JPH01163123A publication Critical patent/JPH01163123A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
JP63281152A 1987-11-11 1988-11-07 ビンクリスチン含有物 Pending JPH01163123A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8702688 1987-11-11
NL8702688 1987-11-11

Publications (1)

Publication Number Publication Date
JPH01163123A true JPH01163123A (ja) 1989-06-27

Family

ID=19850895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63281152A Pending JPH01163123A (ja) 1987-11-11 1988-11-07 ビンクリスチン含有物

Country Status (13)

Country Link
US (1) US5055449A (OSRAM)
EP (1) EP0316030B1 (OSRAM)
JP (1) JPH01163123A (OSRAM)
KR (1) KR890007752A (OSRAM)
AT (1) ATE70454T1 (OSRAM)
AU (1) AU612720B2 (OSRAM)
DE (1) DE3867039D1 (OSRAM)
DK (1) DK628388A (OSRAM)
ES (1) ES2045092T3 (OSRAM)
GR (1) GR3003930T3 (OSRAM)
IE (1) IE883296L (OSRAM)
NZ (1) NZ226915A (OSRAM)
ZA (1) ZA888335B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173521A (en) * 1990-06-19 1992-12-22 Mishima Paper Co., Ltd. Absorbent fibrous structure and producing method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4000154A1 (de) * 1990-01-04 1991-07-11 Symbiotec Gmbh Chemotherapeutisches mittel, insbesondere zur behandlung von krebserkrankungen
WO1993023072A1 (en) * 1992-05-13 1993-11-25 Akzo N.V. Aqueous hexapeptide compositions
US8110829B2 (en) 2007-05-31 2012-02-07 Lg Display Co., Ltd. Array substrate of liquid crystal display and method for fabricating the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173521A (en) * 1990-06-19 1992-12-22 Mishima Paper Co., Ltd. Absorbent fibrous structure and producing method thereof

Also Published As

Publication number Publication date
IE883296L (en) 1989-05-11
ZA888335B (en) 1989-07-26
DK628388D0 (da) 1988-11-10
KR890007752A (ko) 1989-07-05
EP0316030B1 (en) 1991-12-18
AU2490688A (en) 1989-05-11
GR3003930T3 (OSRAM) 1993-03-16
ATE70454T1 (de) 1992-01-15
NZ226915A (en) 1990-08-28
DE3867039D1 (de) 1992-01-30
DK628388A (da) 1989-05-12
AU612720B2 (en) 1991-07-18
ES2045092T3 (es) 1994-01-16
US5055449A (en) 1991-10-08
EP0316030A1 (en) 1989-05-17

Similar Documents

Publication Publication Date Title
HUP0002877A2 (hu) Stabil inzulinkészítmények és eljárás előállításukra
CA2502146A1 (en) Solution formulations of sirolimus and its analogs for cad treatment
RU2008138381A (ru) Режимы дозирования адреналина
US20150164902A1 (en) Concentrated methotrexate solutions
KR20030033002A (ko) 그렐린 길항제
EA002174B1 (ru) Фармацевтические композиции, содержащие гемисульфат элетриптана и кофеин
JPH02101022A (ja) 糖尿病治療用医薬組成物
CN101541743A (zh) 多肽及相关化合物的透皮给药系统
JP3784418B2 (ja) ソマトスタチン類似体およびラパマイシンの配合
US7638556B2 (en) Freeze-dried product of N-[o-(p-pivaloyloxy benzenesulfonylamino)benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof
RU2003125274A (ru) Применение флумазенила в производстве лекарства для лечения алкогольной зависимости
US20050090549A1 (en) Intrathecal gabapentin for treatment of pain
JPH06508607A (ja) 眼を治療するための方法および製品
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
JPH01163123A (ja) ビンクリスチン含有物
ES2215856T3 (es) Solucion de sal monosodica tetrahidrato de n-(o-(p-pivaloiloxibenceno-sulfonilamino)benzoil)glicina y medicamento que contiene esta solucion.
US5380710A (en) Pharmaceutical compositions containing ACTH (1-24) for the therapy of shock conditions and respiratory and cardiocirculatory insufficiences
WO1999059543A1 (en) A pharmaceutical formulation for nasal administration
CA2547873A1 (en) Tetrapeptide regulating blood glucose level in diabetes mellitus
US20240277815A1 (en) Therapeutic Regimens and Methods for Treatment of Cardiovascular Risk Factors using a GLP-1R and GCGR Agonist
US20250367263A9 (en) Therapeutic Regimens and Methods for Treatment of Cardiovascular Risk Factors using a GLP-1R and GCGR Agonist
JPH01501708A (ja) アミノ酸の経鼻投与
RU1803119C (ru) Способ лечени внематочной беременности
JPH06154319A (ja) 治療装置
WO2022175973A1 (en) An injectable composition for long term delivery of nalbuphine or nalbuphine ester prodrug or its salts and use thereof